Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy

BACKGROUND: Real-world data on early treatment of coronavirus disease 2019 (COVID-19) outpatients with newly approved therapies are sparse. AIM: To explore the pattern of use of monoclonal antibodies (mAbs)/antiviral therapies approved for early COVID-19 treatment in non-hospitalized patients from E...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciccimarra, Francesco, Luxi, Nicoletta, Bellitto, Chiara, L’ Abbate, Luca, De Nardo, Pasquale, Savoldi, Alessia, Yeomans, Alison, Molokhia, Mariam, Tacconelli, Evelina, Trifirò, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163563/
https://www.ncbi.nlm.nih.gov/pubmed/37148526
http://dx.doi.org/10.1007/s40259-023-00601-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163563/
https://www.ncbi.nlm.nih.gov/pubmed/37148526
http://dx.doi.org/10.1007/s40259-023-00601-w

Ejemplares similares